NEW YORK, Aug. 28, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX), and certain officers. The class action, filed in the United States District Court for the District of…

NEWARK, N.J. , Aug. 28, 2023 /PRNewswire/ — Mars, Incorporated, a leader in confectionery, snacking, food, and pet care products and services and the maker of some of the world’s most-loved high-quality brands, including M&M’S®, SNICKERS®, BEN’S ORIGINAL™, PEDIGREE®, and IAMS®, announced…

NEW YORK, Aug. 28, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Sea Limited (“Sea” or the “Company”) (NYSE: SE), and certain officers. The class action, filed in the United States District Court for the District of Arizona, Phoenix…

WESTON, Fla., Aug. 28, 2023 /PRNewswire/ — Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions, announced today the initiation of a Phase 2 clinical trial to assess…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.